1. Home
  2. LITB vs MREO Comparison

LITB vs MREO Comparison

Compare LITB & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LITB

LightInTheBox Holding Co. Ltd.

HOLD

Current Price

$3.18

Market Cap

57.1M

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.28

Market Cap

50.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITB
MREO
Founded
2007
2015
Country
Singapore
United Kingdom
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.1M
50.3M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
LITB
MREO
Price
$3.18
$0.28
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$1.50
AVG Volume (30 Days)
4.3K
5.0M
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$500,000.00
Revenue This Year
$14.50
$5,184.20
Revenue Next Year
$11.59
$55.51
P/E Ratio
$10.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$0.20
52 Week High
$4.17
$2.37

Technical Indicators

Market Signals
Indicator
LITB
MREO
Relative Strength Index (RSI) 52.73 44.11
Support Level $2.81 $0.27
Resistance Level $3.35 $0.35
Average True Range (ATR) 0.18 0.02
MACD 0.00 -0.00
Stochastic Oscillator 65.96 21.83

Price Performance

Historical Comparison
LITB
MREO

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is a e-commerce company, providing a diverse range of affordable lifestyle products directly to consumers. Its brands include Ador, a women's fashion brand targeting women aged 35-55; the second is a golf apparel brand focusing on female golfers aged 35 and above; the third is a women's light party dress brand for the age group of 30 and above. It offers customers products through websites and mobile applications. The company operates and reviews its performance in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of the provision of logistic services to companies and individual customers.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: